Three stories explore the race to develop a #vaccine for #COVID19. - First shots at a #coronavirus vaccine: - Pharma giant & US gov't team up - Deliberately infect volunteers? Not so fast, some warn
Johnson & Johnson will use a genetically engineered adenovirus (Ad5) with a SARS-CoV-2 surface protein in its proposed new vaccine - aiming for a billion doses by autumn, overlapping Phase 1 & 2 trials, all to be done on a 'not for profit' basis.
'We have the Ad26 vector. We've made 10 different constructs & tested them all in mic & we took the most immunogenic one. & in parallel, we looked at upscaling in this cell line that allows us to grow the cells at very high density & have a huge output'
Says J&J capacity for 300 mil / year now, 8 mos to set up another 300 mil. See "...We can make 300 million vaccines, in a 2000-liter vessel, on an annual basis...set up the second one in the U.S. ... by the end of the year." Says can partner w others
Under-viewed story. Re-upping. The $1 billion bet: $JNJ/Janssen and US government team up in all-out coronavirus vaccine push
...and the third is an interview with Paul Stoffels, chief scientific officer at J&J, explaining about what could be a $1 billion investment in their own vaccine candidate.
And then there's 's Q&A with leading vaccine researcher Paul Stoffels of , which has teamed up with the US government to develop a vaccine. /3
Is it coincidence that J&J has Mar-a-Lago connections? The $1 billion bet: Pharma giant and U.S. government team up in all-out coronavirus vaccine push | Science | AAAS
The $1 billion bet: Pharma giant and U.S. government team up in all-out coronavirus vaccine push
The $1 billion bet: Pharma giant (Johnson & Johnson) and U.S. government team up in all-out #coronavirus vaccine push #COVID19